News

Filter

Current filters:

AstraZeneca

1 to 9 of 2719 results

AstraZeneca inks deal with Orca for autoimmune disease drugs

AstraZeneca inks deal with Orca for autoimmune disease drugs

25-02-2015

Anglo-Swedish pharma major AstraZeneca and Orca Pharmaceuticals, a UK based biopharmaceutical company,…

AstraZenecaBiotechnologyImmunologicalsInflammatory diseasesLicensingOrca PharmaceuticalsRespiratory and PulmonaryUK

MedImmune and NIST partner on biological therapies

MedImmune and NIST partner on biological therapies

22-02-2015

MedImmune has signed a five-year agreement with the US Department of Commerce’s National Institute…

AstraZenecaBiotechnologyMedImmuneResearchUSA

Cloud computing offers big data solutions to big pharma

Cloud computing offers big data solutions to big pharma

20-02-2015

Pharmaceutical companies spend upwards of a decade and a billion dollars to bring new drugs and therapies…

AstraZenecaCode-NExostarPharmaceuticalResearch

AstraZeneca gets temporary injunction against Actavis over generic Pulmicort Respules

18-02-2015

Ireland-headquartered generics major Actavis yesterday confirmed that the US Court of Appeals for the…

ActavisAstraZenecaGenericsLegalPatentsPulmicort RespulesRespiratory and PulmonaryUSA

Actavis launches generic Pulmicort Respules in USA

14-02-2015

Ireland-based generic drugs major Actavis has launched its generic version of Anglo-Swedish pharma major…

ActavisAstraZenecaGenericsLegalMarkets & MarketingPatentsPulmicort RespulesRespiratory and PulmonaryUSA

AstraZeneca to pay $7.9 million to resolve kickback allegations in USA

AstraZeneca to pay $7.9 million to resolve kickback allegations in USA

12-02-2015

Anglo-Swedish pharma major AstraZeneca has agreed to pay the US government $7.9 million to settle allegations…

AstraZenecaCardio-vascularGastro-intestinalsLegalMarkets & MarketingNexiumPharmaceuticalPlendilPrilosecToprol XLUSA

US DEA de-schedules AstraZeneca’s Movantik

07-02-2015

The USA’s Drug Enforcement Administration (DEA) has de-scheduled UK pharma major AstraZeneca’s Movantik…

AstraZenecaGastro-intestinalsMovantiknaloxegolNektar TherapeuticsPharmaceuticalRegulationUSA

Profits and share price down as AstraZeneca announces fourth quarter and 2014 results

Profits and share price down as AstraZeneca announces fourth quarter and 2014 results

05-02-2015

Anglo-Swedish drug major AstraZeneca met its upgraded guidance for 2014, though both profits and share…

AstraZenecaCrestorFinancialNexiumPharmaceutical

1 to 9 of 2719 results

COMPANY SPOTLIGHT

Menarini

Back to top